7 of them launched during the first several days of July, joining Amgen’s Amjevita in the suddenly crowded market of Humira competitors. Pfizer’s Abrilada is the only FDA-approved Humira biosimilar that hasn’t launched.From none to one and now there eight.Fresenius Kabi and Biocon Biologics announced yesterday that their Humira (adalimumab) biosimilars were on the market […]
